Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2023-01-05 00:00:00 ET · period of report 2023-01-03 · accession 0001765581-23-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-01-05 | 2023-01-03 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | S - Sale | $159.86 | -3,000 | 368.1K | -0.8% | -$479.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-01-03 | S | D | 1,000 | $159.59 | 370,078 | D | — | — | |
| 2 | Common | Ordinary Shares | 2023-01-03 | S | D | 2,000 | $160.00 | 368,078 | D | — | — |